Miller-Rich Nancy Insider Trades

Insider Trading History

Track insider trading activity for Miller-Rich Nancy. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $225k 22,500 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.4k 22,500 shares
$4.15
$10.01
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Director
Holding Value $110k 62,728 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 65,141 shares
$2.69
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Director
Holding Value $70.9k 40,282 shares
Last Trade
Jun 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$172k 42,018 shares
$4.09
$1.76
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $225k 22,500 shares
Last Trade
May 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$566k 22,500 shares
$25.15
$10.01
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Director
Holding Value $0 0 shares
Last Trade
Nov 08, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.11M 58,361 shares
$19.00
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Director
Holding Value $0 0 shares
Last Trade
Nov 08, 2023 Sale (Tender)Reported as Tender on SEC Form 4.
$424k 22,304 shares
$19.00
$19.00
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Director
Holding Value $37.4k 21,222 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$186k 22,137 shares
$8.39
$1.76
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Director
Holding Value $578k 30,415 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$115k 12,547 shares
$9.17
$19.00
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $225k 22,500 shares
Last Trade
May 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405k 22,500 shares
$17.98
$10.01
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Director
Holding Value $1.62k 922 shares
Last Trade
Apr 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.16k 509 shares
$10.13
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Director
Holding Value $94.7k 53,812 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 53,812 shares
$3.60
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Director
Holding Value $4.08k 2,319 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.35k 2,319 shares
$3.60
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Director
Holding Value $4.08k 2,319 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.35k 2,319 shares
$3.60
$1.76
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Director
Holding Value $243k 12,790 shares
Last Trade
May 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$215k 12,790 shares
$16.82
$19.00
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $225k 22,500 shares
Last Trade
May 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 22,500 shares
$7.77
$10.01
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $225k 22,500 shares
Last Trade
May 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 22,500 shares
$7.77
$10.01
Kadmon Holdings
Kadmon Holdings KDMN
Director
Holding Value $0 0 shares
Last Trade
Nov 09, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$345k 36,364 shares
$9.50
$9.50
Kadmon Holdings
Kadmon Holdings KDMN
Director
Holding Value $0 0 shares
Last Trade
Nov 09, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$921k 96,975 shares
$9.50
$9.50
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Director
Holding Value $23.8k 13,534 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$176k 13,534 shares
$12.97
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Director
Holding Value $1.03k 583 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.56k 583 shares
$12.97
$1.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up